What Do Analysts Say About Firefly Neuroscience Inc (AIFF)?

Firefly Neuroscience Inc (AIFF) saw an uptrend of 2.89% in the recent trading with $2.85 being its most recent. The current price level -83.43% lower than the highest price of $17.20 marked by the stock while trading over the past 52-weeks, whereas it is 53.23% higher than the lowest price of $1.86 the company dropped to over past 52-weeks. The latest news story on AIFF appeared in (GlobeNewswire) under the title “Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America”.

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform.

Firefly Neuroscience Inc Earnings – What Happened With AIFF

Coming around sales and income figures on AIFF Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.

Firefly Neuroscience Inc – Insider Activity and Holdings

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 13.30 million. AIFF does have institutional investors; and they hold 10.66% of the stock.

Key Metrics for AIFF

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Firefly Neuroscience Inc has a debt to equity ratio of 0.00.

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.